Clinical Trials Logo

Clinical Trial Summary

Small for gestational age refers to an infant born with a birth weight less than the 10th centile. Severe small for gestational age refers to an infant born with a birth weight less than the 3rd centile. Constitutionally small fetuses are fetuses whose growth at all gestational ages has been low but otherwise healthy. Those babies have a great risk for perinatal morbidity and mortality. Many causes are responsible for the development of Severe small for gestational age, however; in a few cases, the cause could not be detected. In contrast to pathologic intrauterine growth restriction, the constitutionally small fetuses have normal umbilical and middle cerebral artery Doppler velocimetry and normal amniotic fluid volume. In this circumstance, continued biophysical testing and delivery at 38-39 weeks is reasonable. Low birth weight fetuses comprise both preterm births and SGA. They are at a higher risk of adverse birth outcomes. So the trials to increase the blood flow to the uterus and/or the fetus may improve the neonatal outcomes. There are many lines of treatment that have been emerged now for the treatment of small for gestational age fetuses like maternal rest and oxygenation, aspirin therapy, supplementation of zinc, and fish oil. However; all mentioned lines of treatment lack evidence of effectiveness in literature. Omega-3 fatty acids as antioxidants inhibit the free radicals released during pregnancy which are responsible for vasoconstriction; so vasodilatation will occur. This leads to increase blood flow to the uterus and placenta which improves pregnancy outcomes. Progesterone is a smooth muscle relaxant and has a vasodilator effect on the blood vessels. It causes endothelium- relaxation of human placental arteries and veins. This relaxation is significant for maintaining low flow impedance and satisfactory blood flow in the placental circulation. DeFranco et al observed that vaginal progesterone is associated with vascular relaxation and increased uterine blood flow. But, he did not observe this vascular effect in women receiving systemic progesterone. So from the above evidence; there is a need to study the effect of omega 3 and progesterone on pregnant women whose pregnancy is complicated with constitutionally small for gestational age fetuses in trial to find a new line of treatment of this problem.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04161989
Study type Interventional
Source Assiut University
Contact
Status Completed
Phase N/A
Start date May 1, 2020
Completion date June 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03215173 - Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease N/A
Completed NCT03533712 - Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso. Phase 4
Recruiting NCT05901688 - Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Recruiting NCT06315127 - The CanDo (Canadian Donor Milk) Trial N/A
Completed NCT04216706 - Early Vascular Adjustments to Prevent Preeclampsia
Recruiting NCT05855551 - Improving Birth Outcomes in Bangladesh N/A
Not yet recruiting NCT06226051 - Growing Little PEAPODS Study
Completed NCT01728766 - Breast Milk Zinc Transfer to Appropriate- and Small-for-gestational-age Bangladeshi Infants N/A
Recruiting NCT05730569 - Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina Faso
Not yet recruiting NCT06200519 - Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Active, not recruiting NCT05670145 - PRECISE - Objective Measures and Observations of Physical Exposures Among Pregnant Employees in the Danish Workforce
Completed NCT05810545 - Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity
Completed NCT05814198 - Evaluation of HALP Score in Distinction Between FGR and SGA
Recruiting NCT04764461 - Use of Customized GROW Charts for Detection of SGA in Low Risk Woman. N/A
Recruiting NCT04720690 - Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Recruiting NCT06125860 - BEP Targeting Strategies in Ethiopia N/A
Active, not recruiting NCT06074601 - MIRACLE of LIFE Study
Completed NCT03880032 - Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention N/A
Withdrawn NCT05612984 - Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth Phase 3